Nuedexta and Ampyra drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Nuedexta (dextromethorphan hydrobromide; quinidine sulfate) and Ampyra (dalfampridine). Common drug interactions include muscle spasticity among females and multiple sclerosis relapse among males.
The phase IV clinical study analyzes what interactions people have when they take Nuedexta and Ampyra. It is created by eHealthMe based on reports of 333 people who take the same drugs from the FDA, and is updated regularly.
What is Nuedexta?
Nuedexta has active ingredients of dextromethorphan hydrobromide; quinidine sulfate. eHealthMe is studying from 3,781 Nuedexta users. Check the latest studies of Nuedexta.
What is Ampyra?
Ampyra has active ingredients of dalfampridine. It is often used in multiple sclerosis. eHealthMe is studying from 77,145 Ampyra users. Check the latest studies of Ampyra.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
333 people who take Nuedexta and Ampyra together, and have interactions are studied.
What are the common drug interactions of Nuedexta and Ampyra, by gender? *
What are the common drug interactions of Nuedexta and Ampyra, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Nuedexta and Ampyra?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Nuedexta and Ampyra:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nuedexta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ampyra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nuedexta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ampyra and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on dextromethorphan hydrobromide; quinidine sulfate and dalfampridine (the active ingredients of Nuedexta and Ampyra, respectively), and Nuedexta and Ampyra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Dilaudid and Weight Gain - Unintentional for Women aged 20-29 - 5 seconds ago
- Dilaudid and Weight Gain for Women aged 20-29 - 5 seconds ago
- Dilaudid and Weight Increased for Women aged 20-29 - 5 seconds ago
- Ramipril and Stiff Neck for Men aged 60+ - 12 seconds ago
- Ramipril and Pain - Neck for Men aged 60+ - 12 seconds ago
- Ramipril and Neck Stiffness for Men aged 60+ - 12 seconds ago
- Ramipril and Cervical Spine Pain for Men aged 60+ - 13 seconds ago
- Ramipril and Neck Pain for Men aged 60+ - 13 seconds ago
- Could Eliquis cause Blood Sodium Abnormal? - 14 seconds ago
- Drug interactions of Levocarnitine and Profen - 28 seconds ago